Dr. Muhammed Majeed, founder and chairman of Sabinsa, recently announced the publication of his fourth book about Boswellia serrata, called “Boswellin – Anti-inflammatory Adaptogen from Nature.” Boswellin is the company’s proprietary ingredient sourced from Boswellia.
 
The new book on Boswellia captures scientific understanding on acids unique to the plant, called Boswellic acids, and breaks new ground by delving into the polysaccharide component of Boswellia gum.
 
Boswellic acids are obtained from the gum resin of the Boswellia serrata tree, a large, branching, deciduous tree which grows abundantly in the dry, hilly parts of India. The gum resin exudate of Boswellia serrata, known in the vernacular as “Salai guggal,” has been in use in Ayurvedic system of medicine for the management of a number of health conditions. The primary use of Boswellia serrata in contemporary supplementation targets the inflammatory response through the pharmacological agents found in the plant.
 
The Boswellin range of Boswellia serrata extracts was introduced by the Sami-Sabinsa Group to the nutritional industry in the 1990s, when components of the Boswellia plant were identified to have inflammatory-modulating properties by inhibiting LOX, a subject of intense interest for three decades.
 
Boswellin PS is a nutritional ingredient composed of both Boswellic acids and polysaccharide of the gum.
 
“With many botanicals, there is so much more to study than the primarily-known active constituents,” Majeed said. “In studying Boswellia, we’ve made some intriguing discoveries about the immunomodulatory polysaccharides of Boswellia gum, and are eager to share those more widely.”
 
The book can be obtained for free by contacting Sabinsa at info@sabinsa.com.